logo

For the Inventor, By the Inventor

Urawa, Japan

Kazuo Kubo

This inventor holds 9 USPTO granted patents. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1979-1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuo Kubo. Retrieved from https://idiyas.com/inventor/kazuo-kubo-bf51f9j7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 55(Granted Patents)


Location History:

  • Urawa, JP (1979 - 1982)
  • Saitama, JP (1987)

Company Filing History:

goldMedal9 out of 329 
 
Yamanouchi Pharmaceutical Company Ltd.
 patents

Years Active: 1979-1987

Loading Chart...
9 patents (USPTO):Explore Patents
1. 4636516 - 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds (1987-01-13),
2. 4335129 - Thiazolo[3,2-6]isoquinolines, compositions and use thereof (1982-06-15),
3. 4329455 - 1,3-Oxazino(3,2-b)isoquinoline-6-ones (1982-05-11),
4. 4288438 - Nitrogen-containing heterocyclic ring derivatives and analgesic and (1981-09-08),
5. 4284778 - Nitrogen-containing heterocyclic ring derivatives (1981-08-18),
6. 4251533 - Nitrogen-containing heterocyclic compounds (1981-02-17),
7. 4198512 - 1-Oxo-1,2-dihydroisoquinoline derivatives (1980-04-15),
8. 4186200 - Novel fused derivatives of 2-pyridones (1980-01-29),
9. 4163844 - Nitrogen-containing heterocyclic compounds (1979-08-07),

Title: Kazuo Kubo: Innovator in Heterocyclic Compounds

Introduction

Kazuo Kubo is a prominent inventor based in Urawa, Japan. He has made significant contributions to the field of chemistry, particularly in the development of novel heterocyclic compounds. With a total of nine patents to his name, Kubo's work has had a substantial impact on pharmaceutical research and development.

Latest Patents

Kubo's latest patents include innovative compounds such as 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds. These compounds exhibit anti-inflammatory, anti-pyretic, analgesic, anti-arthritic, and immunoregulatory activities, making them particularly useful as antirheumatics. Another notable patent involves thiazolo[3,2-6]isoquinolines, which are nitrogen-containing heterocyclic compounds with various potential applications in medicine.

Career Highlights

Kazuo Kubo has spent a significant portion of his career at Yamanouchi Pharmaceutical Company Ltd. His work has been instrumental in advancing the understanding and application of heterocyclic compounds in therapeutic settings. Kubo's dedication to research and innovation has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Throughout his career, Kubo has collaborated with esteemed colleagues such as Yasuo Isomura and Hiroshige Homma. These partnerships have fostered a collaborative environment that has led to groundbreaking discoveries in the field of chemistry.

Conclusion

Kazuo Kubo's contributions to the field of heterocyclic compounds have established him as a leading inventor in pharmaceutical research. His innovative patents and collaborations continue to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…